Why the Resonance Health (ASX:RHT) share price is shooting 39% higher today

The Resonance Health Limited (ASX: RHT) share price is shooting the lights out today. This comes after the company announced it has received a 510(k) clearance from the United States Food and Drug Administration (FDA) for its HepaFat-AI software.

At the time of writing, the Resonance Health share price is up 38.7% to 21.5 cents. In comparison, the All Ordinaires Index (ASX: XAO) is up 0.7% to 6,969 points.

What’s driving the Resonance Health share price?

The Resonance Health share price is surging today following the company’s positive FDA clearance announcement.

According to Resonance Health, the FDA has cleared the pathway for the company to begin commercialisation for its HepaFat-AI technology.

HepaFat-AI is a medical…